Agra Ventures Announces Results of its Annual General & Special Meeting

Press Release

Vancouver, British Columbia / – Agra Ventures Ltd. (“AGRA” or the “Company”) (CSE: AGRA) (OTCPK: AGFAF), a company focused on the cannabis industry, is pleased to provide the voting results from its Annual General & Special Meeting (“AGSM“) that was held today in Vancouver, British Columbia. A total of 43,331,793 common shares of the Company were voted, representing 27.09% of AGRA’s outstanding shares. Shareholders voted in favour of all applicable items of business set before the meeting, as follows:

Nick Kuzyk, Fiona Fitzmaurice, Anthony Carnevale, and Jonathan Hirsh were all re-elected to the Board of Directors at the AGSM.

Share Consolidation

On May 30, 2023 and June 2, 2023, the Company announced a proposed share consolidation (the “Share Consolidation”) whereby Shareholders will receive one (1) post-consolidation voting common share for up to twenty-five (25) pre-consolidation voting common shares held by them.

As the Company has now received the requisite shareholder approval, it will be proceeding with the Share Consolidation. Details including the new CUSIP/ISIN numbers and effective date will be announced in an upcoming news release.

About Agra Ventures Ltd.

Agra Ventures is a company focused on the cannabis industry. The company’s wholly owned subsidiary, Farmako GmbH, is focused on becoming Europe’s leading distributor of medical cannabis as well as its proprietary CBD and THC test kits. Farmako currently has active product distribution operations in Germany and is fully licensed in the United Kingdom.

For more information about Agra Ventures, please visit www.agraventures.com and its profile page on SEDAR at www.sedar.com.

ON BEHALF OF THE BOARD OF DIRECTORS

Nick Kuzyk, CEO & Director
E: ir@agraventures.com
T: (800) 783-6056

IBF4